Find a Pharmacy
Vertice Login
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Category: Workers Comp

517 posts found

Gabapentin-Involved Overdose Deaths on the Rise

A new report from the CDC found that 10% of overdose deaths in 2019-2020 involved gabapentin.
Read More

Rhode Island Legalizes Recreational Marijuana

A total of 19 states now allow for recreational marijuana in adults aged 21 and older.
Read More

Why Novel Physical Therapy Strategies are Getting Attention from Workers’ Comp

Risk and Insurance® magazine speaks to industry professionals, including Healthe’s Director of Product Management, Tate Rice.
Read More

FDA Issues Warning for Consumer Products with Hidden Pain Medications

Undeclared muscle relaxants and anti-inflammatory drugs could interact with a patient’s care.
Read More

Giving Notice: How Workforce Attrition Impacts Workers’ Comp

Millions of workers are changing occupations, leading to ripple effects for comp.
Read More

IQVIA Reports on Trends and Future Outlook for Drug Utilization and Spend

Spending and utilization are returning to pre-pandemic levels, with biologics growing in prominence.
Read More

FDA Considers Requiring Mail-Back Envelopes for Opioid Prescriptions

The public comment period is underway for this action, which could help with safer drug disposal.
Read More

Silvia Sacalis to Join Panel Presentation at PRIMA 2022

Healthe’s VP of Clinical Services will join a discussion on post-COVID lessons for workers’ comp.
Read More

Phase 2 Trials for Non-Opioid Pain Medication Deliver Promising Results

VX-548 delivered significant improvements in pain with few adverse events.
Read More

Out of Balance: Workforce Gender Disparities and What They Mean for Workers’ Comp

Women workers were more adversely impacted by the pandemic and the recession.
Read More

Positive Marijuana Drug Screenings Reach All Time High

Quest Diagnostics reports increased positivity rates for marijuana in employee drug screenings.
Read More

FDA Authorizes Second COVID-19 Booster Dose for Special Populations

Adults aged 50 and older and immunocompromised individuals may receive a second booster dose.
Read More

NCCI Reports on Return-to-Work Strategies

Carriers share their thoughts on successful RTW programs.
Read More

FDA Approves Fleqsuvy for Spasticity

A new muscle relaxant for the treatment of spasticity, including from spinal cord injuries.
Read More

2022 Workers’ Comp Industry Insights Survey Report

Nearly 500 stakeholders share their thoughts on industry challenges and priorities.
Read More
1 2 3 4 5 13 14 15 16 17 31 32 33 34 35
lockmap-markermagnifiercrossmenuarrow-rightcross-circle